FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:516-518 January 29, 2004 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Manolio, T. Related Article by Brennan, M.-L. PubMed Citation

To the Editor: Brennan et al. (Oct. 23 issue)¹ report an intriguing study of myeloperoxidase in the evaluation of patients with acute chest pain. However, the use of a test for clinical prediction also requires decisions about the sensitivity and specificity of any selected cutoff point.² The only information of this type provided in the article is the evaluation of the creatine kinase MB isoform (CK-MB), C-reactive protein, and myeloperoxidase for the prediction of major cardiac events within 30 days in patients with chest pain and normal troponin T levels. When the sensitivities and specificities are combined into likelihood ratios, . . . [Full Text of this Article]

This article has been cited by other articles:

• Cuccurullo, C., Iezzi, A., Fazia, M. L., De Cesare, D., Di Francesco, A., Muraro, R., Bei, R., Ucchino, S., Spigonardo, F., Chiarelli, F., Schmidt, A. M., Cuccurullo, F., Mezzetti, A., Cipollone, F. (2006). Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes. Arterioscler. Thromb. Vasc. Bio. 26: 2716-2723 [Abstract] [Full Text]  
• Tsimikas, S., Willerson, J. T., Ridker, P. M. (2006). C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.. J Am Coll Cardiol 47: C19-C31 [Abstract] [Full Text]  
• Giugliano, R. P., Braunwald, E. (2005). The Year in Non--ST-Segment Elevation Acute Coronary Syndromes. J Am Coll Cardiol 46: 906-919 [Full Text]  
• Nicholls, S. J., Hazen, S. L. (2005). Myeloperoxidase and Cardiovascular Disease. Arterioscler. Thromb. Vasc. Bio. 25: 1102-1111 [Abstract] [Full Text]  
• Klebanoff, S. J. (2005). Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77: 598-625 [Abstract] [Full Text]  
• Hazen, S. L. (2004). Myeloperoxidase and Plaque Vulnerability. Arterioscler. Thromb. Vasc. Bio. 24: 1143-1146 [Full Text]